Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check3 days agoChange DetectedUpdated to 35 locations (including Vancouver, WA) and added new contacts/investigators (Susan Papenfuse; Anthony Van Ho, MD; Kartik Konduri, MD); removed the old 34-location entry and former PI; revision bumped to v3.0.2.SummaryDifference2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as the introduction of new drug names such as sotorasib and defactinib. However, many previous location details and related topics have been removed.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.